Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes

Genes and Immunity

Volumn 16, Issue 7, 2015, Pages 470-480

  Miller, F W ^a   Chen, W ^b   O'Hanlon, T P ^a   Cooper, R G ^c   Vencovsky, J ^d   Rider, L G ^a   Danko, K ^e   Wedderburn, L R ^f   Lundberg, I E ^g   Pachman, L M ^h   Reed, A M ⁱ   Ytterberg, S R ⁱ   Padyukov, L ^g   Selva O'Callaghan, A ^j   Radstake, T R ^k   Isenberg, D A ^l   Chinoy, H ^m   Ollier, W E R ^m   Scheet, P ^b   Peng, B ^b   Lee, A ⁿ   Byun, J ^o   Lamb, J A ^m   Gregersen, P K ⁿ   Amos, C I ^o   more..

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d CHARLES UNIVERSITY   (Czech Republic)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ MAYO CLINIC   (United States)

^j HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^k UTRECHT UNIVERSITY   (Netherlands)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY OF MANCHESTER   (United Kingdom)

ⁿ FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^o DARTMOUTH MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTIDINE TRANSFER RNA LIGASE; HLA ANTIGEN; HUMAN LEUKOCYTE ANTIGEN 8.1; JO 1 ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HAPLOTYPE; HLA SYSTEM; HUMAN; JUVENILE DERMATOMYOSITIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; META ANALYSIS (TOPIC); MYOSITIS; PHENOTYPE; POLYMYOSITIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; CASE CONTROL STUDY; CAUCASIAN; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; ALLELES; AUTOANTIBODIES; CASE-CONTROL STUDIES; DERMATOMYOSITIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; MYOSITIS; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMYOSITIS; RISK FACTORS;

EID: 84945485554     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.28     Document Type: Article

References (46)

1. Parkes M, Cortes A, van Heel DA, Brown M.A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat Rev Genet 2013; 14: 661-673.
2. Ricano-Ponce I, Wijmenga C. Mapping of immune-mediated disease genes. Annu Rev Genomics Hum Genet 2013; 14: 325-353.
3. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 2011; 305: 183-190.
4. Ginn LR, Lin JP, Plotz PH, Bale SJ, Wilder RL, Mbauya A et al. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum 1998; 41: 400-405.
5. Niewold TB, Wu SC, Smith M, Morgan GA, Pachman LM. Familial aggregation of autoimmune disease in juvenile dermatomyositis. Pediatrics 2011; 127: e1239-e1246.
6. Scott AP, Laing NG, Mastaglia F, Needham M, Walter MC, Dalakas MC et al. Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex. J Neuroimmunol 2011; 235: 77-83.
7. O'Hanlon TP, Carrick DM, Targoff IN, Arnett FC, Reveille JD, Carrington M et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A,-B,-Cw,-DRB1, and-DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006; 85: 111-127.
8. Chinoy H, Salway F, Fertig N, Shephard N, Tait BD, Thomson W et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 2006; 8: R13.
9. Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet 2013; 14: 301-323.
10. Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, Almeida J et al. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 2008; 60: 1-18.
11. Miller FW. Inflammatory myopathies: polymyositis, dermatomyositis, and related conditions. In: Koopman W, Moreland L (eds.) Arthritis and Allied Conditions, A Textbook of Rheumatology; Vol 15. Lippincott, Williams and Wilkins: Philadelphia, 2005: 1593-1620.
12. Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford) 2015; 54: 50-63.
13. Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum 2013; 65: 3239-3247.
14. Mitchell MK, Gregersen PK, Johnson S, Parsons R, Vlahov D. New York Cancer P The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health 2004; 81: 301-310.
15. Wellcome Trust Case Control C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447: 661-678.
16. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-1209.
17. O'Hanlon TP, Miller FW. Genetic risk and protective factors for the idiopathic inflammatory myopathies. Curr Rheumatol Rep 2009; 11: 287-294.
18. Chinoy H, Lamb JA, Ollier WE, Cooper RG. Recent advances in the immunoge-netics of idiopathic inflammatory myopathy. Arthritis Res Ther 2011; 13: 216.
19. Chinoy H, Payne D, Poulton KV, Fertig N, Betteridge Z, Gunawardena H et al. HLA-DPB1 associations differ between DRB1∗03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy. Rheumatology (Oxford) 2009; 48: 1213-1217.
20. Pinto D, Darvishi K, Shi X, Rajan D, Rigler D, Fitzgerald T et al. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol 2011; 29: 512-520.
21. Hassan AB, Nikitina-Zake L, Sanjeevi CB, Lundberg IE, Padyukov L. Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1∗03) with polymyositis and dermatomyositis. Arthritis Rheum 2004; 50: 1013-1015.
22. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 360-374.
23. Miller FW. Myositis-specific autoantibodies. Touchstones for understanding the inflammatory myopathies. JAMA 1993; 270: 1846-1849.
24. Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013; 92: 223-243.
25. Casciola-Rosen L, Mammen AL. Myositis autoantibodies. Curr Opin Rheumatol 2012; 24: 602-608.
26. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629-644.
27. Candore G, Lio D, Colonna RG, Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002; 1: 29-35.
28. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 257-274.
29. Chinoy H, Salway F, John S, Fertig N, Tait BD, Oddis CV et al. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Rheumatology (Oxford) 2007; 46: 1411-1416.
30. Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E et al. Interaction of HLA-DRB1∗03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis 2012; 71: 961-965.
31. Rothwell S, Cooper RG, Lamb JA, Chinoy H. Entering a new phase of immunogenetics in the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2013; 25: 735-741.
32. Kaslow RA, Shaw S. The role of histocompatibility antigens (HLA) in infection. Epidemiol Rev 1981; 3: 90-114.
33. Xie Z, Chang C, Zhou Z. Molecular mechanisms in autoimmune type 1 diabetes: a critical review. Clin Rev Allergy Immunol 2014; 47: 174-192.
34. Candore G, Campagna AM, Cuppari I, Di CD, Mineo C, Caruso C. Genetic control of immune response in carriers of the 8.1 ancestral haplotype: correlation with levels of IgG subclasses: its relevance in the pathogenesis of autoimmune diseases. Ann NY Acad Sci 2007; 1110: 151-158.
35. Candore G, Balistreri CR, Campagna AM, Colombo A, Cuppari I, Di-Carlo D et al. Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of chemotaxis. Ann NY Acad Sci 2006; 1089: 509-515.
36. Olivares M, Laparra JM, Sanz Y. Host genotype, intestinal microbiota and inflammatory disorders. Br J Nutr 2013; 109: S76-S80.
37. Olivares M, Neef A, Castillejo G, Palma GD, Varea V, Capilla A et al. The HLA-DQ2 genotype selects for early intestinal microbiota composition in infants at high risk of developing coeliac disease. Gut 2014; 64: 406-417.
38. Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255-286.
39. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 1993; 91: 2556-2564.
40. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
41. Rich SS, Concannon P, Erlich H, Julier C, Morahan G, Nerup J et al. The Type 1 Diabetes Genetics Consortium. Ann NY Acad Sci 2006; 1079: 1-8.
42. Erlich HA, Lohman K, Mack SJ, Valdes AM, Julier C, Mirel D et al. Association analysis of SNPs in the IL4R locus with type I diabetes. Genes Immun 2009; 10: S33-S41.
43. Concannon P, Chen WM, Julier C, Julier C, Morahan G, Akolkar B et al. Genome-wide scan for linkage to type 1 diabetes in 2, 496 multiplex families from the Type 1 Diabetes Genetics Consortium. Diabetes 2009; 58: 1018-1022.
44. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
45. Evangelou E, Ioannidis JP. Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet 2013; 14: 379-389.
46. Begum F, Ghosh D, Tseng GC, Feingold E. Comprehensive literature review and statistical considerations for GWAS meta-analysis. Nucleic Acids Res 2012; 40: 3777-3784.